| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis
|
Liu, Hong
|
|
|
37 |
3 |
p. 324-339.e8
|
article
|
| 2 |
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
|
Goveia, Jermaine
|
|
|
37 |
3 |
p. 421
|
article
|
| 3 |
Breaking Down the Barriers to Define and Treat NK/T Cell Lymphoma
|
Mundy-Bosse, Bethany
|
|
|
37 |
3 |
p. 263-265
|
article
|
| 4 |
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma
|
Salvador-Barbero, Beatriz
|
|
|
37 |
3 |
p. 340-353.e6
|
article
|
| 5 |
Chemotherapy and CDK4/6 Inhibition in Cancer Treatment: Timing Is Everything
|
Fassl, Anne
|
|
|
37 |
3 |
p. 265-267
|
article
|
| 6 |
Context-Dependent Immune Responses Explain Pancreatic Cancer Immunoresistance
|
Bednar, Filip
|
|
|
37 |
3 |
p. 261-263
|
article
|
| 7 |
Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells
|
Sagnella, Sharon M.
|
|
|
37 |
3 |
p. 354-370.e7
|
article
|
| 8 |
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
|
Hegde, Samarth
|
|
|
37 |
3 |
p. 289-307.e9
|
article
|
| 9 |
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|
Xiong, Jie
|
|
|
37 |
3 |
p. 403-419.e6
|
article
|
| 10 |
It’s All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice
|
Gundry, Michael C.
|
|
|
37 |
3 |
p. 267-269
|
article
|
| 11 |
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
|
Huang, Huilin
|
|
|
37 |
3 |
p. 270-288
|
article
|
| 12 |
Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas
|
Fortin, Jerome
|
|
|
37 |
3 |
p. 308-323.e12
|
article
|
| 13 |
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer
|
Zheng, Ze-Yi
|
|
|
37 |
3 |
p. 387-402.e7
|
article
|
| 14 |
Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity
|
Robichaux, Jacqulyne P.
|
|
|
37 |
3 |
p. 420
|
article
|
| 15 |
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
|
McGrail, Daniel J.
|
|
|
37 |
3 |
p. 371-386.e12
|
article
|
Journal description